Literature DB >> 25359999

An optimized disaggregation method for human lung tumors that preserves the phenotype and function of the immune cells.

Jon G Quatromoni1, Sunil Singhal1, Pratik Bhojnagarwala1, Wayne W Hancock1, Steven M Albelda1, Evgeniy Eruslanov2.   

Abstract

Careful preparation of human tissues is the cornerstone of obtaining accurate data in immunologic studies. Despite the essential importance of tissue processing in tumor immunology and clinical medicine, current methods of tissue disaggregation have not been rigorously tested for data fidelity. Thus, we critically evaluated the current techniques available in the literature that are used to prepare human lung tumors for immunologic studies. We discovered that these approaches are successful at digesting cellular attachments and ECMs; however, these methods frequently alter the immune cell composition and/or expression of surface molecules. We thus developed a novel approach to prepare human lung tumors for immunologic studies by combining gentle mechanical manipulation with an optimized cocktail of enzymes used at low doses. This enzymatic digestion cocktail optimized cell yield and cell viability, retrieved all major tumor-associated cell populations, and maintained the expression of cell-surface markers for lineage definition and in vivo effector functions. To our knowledge, we present the first rigorously tested disaggregation method designed for human lung tumors. © Society for Leukocyte Biology.

Entities:  

Keywords:  collagenase; enzymatic digestion; tumor-infiltrating immune cells

Mesh:

Year:  2014        PMID: 25359999      PMCID: PMC4771617          DOI: 10.1189/jlb.5TA0814-373

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  31 in total

1.  Collagenase digestion and mechanical disaggregation as a method to extract and immunophenotype tumour lymphocytes in cutaneous T-cell lymphomas.

Authors:  M Novelli; P Savoia; I Cambieri; R Ponti; A Comessatti; F Lisa; M G Bernengo
Journal:  Clin Exp Dermatol       Date:  2000-07       Impact factor: 3.470

Review 2.  Dissociation of cells from solid tumors.

Authors:  R Cerra; R J Zarbo; J D Crissman
Journal:  Methods Cell Biol       Date:  1990       Impact factor: 1.441

3.  Tissue disaggregation.

Authors:  Robert E Cunningham
Journal:  Methods Mol Biol       Date:  2010

4.  Collagenase and Dispase enzymes disrupt lymphocyte surface molecules.

Authors:  M Abuzakouk; C Feighery; C O'Farrelly
Journal:  J Immunol Methods       Date:  1996-08-14       Impact factor: 2.303

5.  Immunosuppressive activity of CD14+ HLA-DR- cells in squamous cell carcinoma of the head and neck.

Authors:  Kazuaki Chikamatsu; Koichi Sakakura; Minoru Toyoda; Katsumasa Takahashi; Takanori Yamamoto; Keisuke Masuyama
Journal:  Cancer Sci       Date:  2012-04-11       Impact factor: 6.716

6.  An enzymatic method for the consistent production of monodispersed viable cell suspensions from human solid tumors.

Authors:  G H Rong; E A Grimm; W F Sindelar
Journal:  J Surg Oncol       Date:  1985-02       Impact factor: 3.454

7.  Phenotypic characterization and functional analysis of human tumor immune infiltration after mechanical and enzymatic disaggregation.

Authors:  Cécile Grange; Jason Létourneau; Marie-Andrée Forget; Jessica Godin-Ethier; Jocelyne Martin; Moishe Liberman; Mathieu Latour; Hugues Widmer; Jean-Baptiste Lattouf; Ciriaco A Piccirillo; Jean-François Cailhier; Réjean Lapointe
Journal:  J Immunol Methods       Date:  2011-07-18       Impact factor: 2.303

8.  Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage.

Authors:  Ivan Perrot; Dominique Blanchard; Nathalie Freymond; Sylvie Isaac; Benoît Guibert; Yves Pachéco; Serge Lebecque
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

9.  A rapid technique for isolation of viable tumor cells from solid tumors: use of the tumor cells for induction and measurement of cell-mediated cytotoxic responses.

Authors:  E Kedar; B L Ikejiri; G D Bonnard; R B Herberman
Journal:  Eur J Cancer Clin Oncol       Date:  1982-10

10.  Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma.

Authors:  Bin Zhang; Zhijun Wang; Liangliang Wu; Meng Zhang; Wei Li; Jianhua Ding; Jun Zhu; Huafeng Wei; Ke Zhao
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

View more
  29 in total

1.  Phenotypic and functional analysis of malignant mesothelioma tumor-infiltrating lymphocytes.

Authors:  Astero Klampatsa; Shaun M O'Brien; Jeffrey C Thompson; Abhishek S Rao; Jason E Stadanlick; Marina C Martinez; Maria Liousia; Edward Cantu; Keith Cengel; Edmund K Moon; Sunil Singhal; Evgeniy B Eruslanov; Steven M Albelda
Journal:  Oncoimmunology       Date:  2019-07-13       Impact factor: 8.110

Review 2.  Mouse versus Human Neutrophils in Cancer: A Major Knowledge Gap.

Authors:  Evgeniy B Eruslanov; Sunil Singhal; Steven M Albelda
Journal:  Trends Cancer       Date:  2017-01-19

3.  Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer.

Authors:  Sunil Singhal; Jason Stadanlick; Michael J Annunziata; Abhishek S Rao; Pratik S Bhojnagarwala; Shaun O'Brien; Edmund K Moon; Edward Cantu; Gwenn Danet-Desnoyers; Hyun-Jeong Ra; Leslie Litzky; Tatiana Akimova; Ulf H Beier; Wayne W Hancock; Steven M Albelda; Evgeniy B Eruslanov
Journal:  Sci Transl Med       Date:  2019-02-13       Impact factor: 17.956

4.  Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer.

Authors:  Sunil Singhal; Pratik S Bhojnagarwala; Shaun O'Brien; Edmund K Moon; Alfred L Garfall; Abhishek S Rao; Jon G Quatromoni; Tom Li Stephen; Leslie Litzky; Charuhas Deshpande; Michael D Feldman; Wayne W Hancock; Jose R Conejo-Garcia; Steven M Albelda; Evgeniy B Eruslanov
Journal:  Cancer Cell       Date:  2016-06-30       Impact factor: 31.743

5.  The protumorigenic potential of FTY720 by promoting extramedullary hematopoiesis and MDSC accumulation.

Authors:  Y Li; T Zhou; Y Wang; C Ning; Z Lv; G Han; J C Morris; E N Taylor; R Wang; H Xiao; C Hou; Y Ma; B Shen; J Feng; R Guo; Y Li; G Chen
Journal:  Oncogene       Date:  2017-02-20       Impact factor: 9.867

Review 6.  Phenotype and function of tumor-associated neutrophils and their subsets in early-stage human lung cancer.

Authors:  Evgeniy B Eruslanov
Journal:  Cancer Immunol Immunother       Date:  2017-03-10       Impact factor: 6.968

7.  Optimal identification of human conventional and nonconventional (CRTH2-IL7Rα-) ILC2s using additional surface markers.

Authors:  Sucai Liu; Kapil Sirohi; Mukesh Verma; Jerome McKay; Lidia Michalec; Anand Sripada; Tomas Danhorn; Donald Rollins; James Good; Magdalena M Gorska; Richard J Martin; Rafeul Alam
Journal:  J Allergy Clin Immunol       Date:  2020-02-04       Impact factor: 10.793

8.  Human lung tumor FOXP3+ Tregs upregulate four "Treg-locking" transcription factors.

Authors:  Tatiana Akimova; Tianyi Zhang; Dmitri Negorev; Sunil Singhal; Jason Stadanlick; Abhishek Rao; Michael Annunziata; Matthew H Levine; Ulf H Beier; Joshua M Diamond; Jason D Christie; Steven M Albelda; Evgeniy B Eruslanov; Wayne W Hancock
Journal:  JCI Insight       Date:  2017-08-17

9.  Intra-tumoral delivery of CXCL11 via a vaccinia virus, but not by modified T cells, enhances the efficacy of adoptive T cell therapy and vaccines.

Authors:  Edmund K Moon; Liang-Chuan S Wang; Kheng Bekdache; Rachel C Lynn; Albert Lo; Stephen H Thorne; Steven M Albelda
Journal:  Oncoimmunology       Date:  2018-01-09       Impact factor: 8.110

10.  Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non-Small Cell Lung Cancer.

Authors:  Shaun M O'Brien; Astero Klampatsa; Jeffrey C Thompson; Marina C Martinez; Wei-Ting Hwang; Abishek S Rao; Jason E Standalick; Soyeon Kim; Edward Cantu; Leslie A Litzky; Sunil Singhal; Evgeniy B Eruslanov; Edmund K Moon; Steven M Albelda
Journal:  Cancer Immunol Res       Date:  2019-05-03       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.